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Does Maternal Methadone Dose Correlate with Severity of Intrauterine Growth Restriction in Infants with 
Neonatal Abstinence Syndrome? 
 
D. Friedman, J. Smith, M. Lafferty, and Z.H. Aghai*  
(*) indicates primary project advisor 
(**) indicates another student who is declaring the same project as primary for SI 
  
  
Introduction​: Previous studies demonstrate a relationship between maternal opioid use during pregnancy and 
smaller head circumference of infants with neonatal abstinence syndrome (NAS). The goal of this study is to correlate 
maternal methadone dose and severity of growth restriction in infants with NAS admitted to the neonatal intensive 
care unit (NICU). 
 
Methods:​ This is a retrospective analysis of infants (≥35 weeks gestation) exposed to in utero methadone, born 
between August 2006 and May 2018, and admitted to a Philadelphia NICU for medical therapy for NAS. Growth 
parameters (birth weight, birth length, and birth head circumference) were compared between infants exposed 
various doses of methadone. The groups were compared using ANOVA, Post-Hoc Tukey, Chi-square and extended 
Fisher exact tests.  
 
Results:​  A total of 686 infants met the study criteria; 109 in the High dose group, 359 in the Intermediate dose 
group, and 218 in the Low dose group. There was no significant difference in the use of other drugs or smoking 
during the pregnancy. Infants exposed to higher doses of methadone displayed significantly smaller head 
circumferences and lengths at birth. The mean birth weight was similar between the three groups. 
 
Discussion:​ There may be a danger in prescribing high doses of methadone to pregnant mothers, as they may 
hinder the growth of the infant. We need to conduct more studies investigating how low head circumference and 
length affect long term developmental outcomes. These findings may help guide physicians toward the optimum dose 
of methadone for mothers.  
 
 
